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Abstract
Microbial-catalyzed biotransformations have considerable potential for the gen-
eration of an enormous variety of structurally diversified organic compounds,
especially natural products with complex structures like triterpenoids, flavonoids,
steroids, steroidal saponins, and sesquiterpenoids. They offer efficient and eco-
nomical ways to produce semisynthetic analogues and novel lead molecules. Micro-
organisms such as bacteria and fungi could catalyze chemo-, regio-, and stereospecific
hydroxylations of diverse substrates that are extremely difficult to produce by
chemical routes. During recent years, considerable research has been performed on
the microbial transformation of bioactive compounds, in order to obtain biologi-
cally active molecules with diverse structural features. In green chemistry,
biotransformations are an important chemical methodology toward more
sustainable industrial processes.
Keywords: microorganisms, fungi, bacteria, microbial transformation,
natural products, enzymes
1. Introduction
Microbial transformation is regarded as an enzymatic reaction by using the
metabolic activities of microorganisms to modify the chemical structures of bioac-
tive substrates for finding the new chemical derivatives with the potent bioactivities
and physical-chemical characteristics. It has a number of advantages over chemical
synthesis such as higher stereo- and regioselectivity but is also enantiospecific,
allowing the production of chiral products from racemic mixtures. The conditions
for biotransformations are mild, and in the majority of cases, they do not require the
protection of pre-existing functional groups. Furthermore, some reactions that do
not occur when using chemical approaches are easily carried out by microbial
transformation. Microbial factories show advantages, for instance, growing rapidly
and ease of large-scale production [1–3].
The use of microorganisms may be a highly efficient method of production of
these compounds. The reactions involved in biotransformation of organic com-
pounds by whole cells of various microorganisms include oxidation, reduction,
hydroxylation, esterification, methylation, demethylation, isomerization, hydroly-
sis, glycosylation, and hydrogenation [4, 5].
Biotransformation may be carried out with isolated enzyme systems or with
intact organism. Although isolated enzyme systems may be more specific and
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efficient for certain biotransformation, these reactions may involve isolating the
enzyme system, and, for some classes of enzyme-catalyzed reaction, a recycling
sequence may be required to regenerate the enzyme [6].
Fungi are playing a prominent role in the catalysis of organic compounds and in
the production of commercially and industrially important compounds, because of
their ability to catalyze novel reactions [7]. Fungi are commonly used in the indus-
try for production of fermented beverages, foods, physiologically active substances,
solvents, organic acids, polysaccharides, antibiotics, etc. Of the zygomycota, Mucor
and Rhizopus are commonly used in the industry. Rhizopus strains are important in
citric acid production.Mucor strains make a significant number of important lipases
and catalyze the hydroxylation of a wide range of chemical compounds [2–4].
The use of the microbial model offers a number of advantages over the use of
animals in metabolism studies, mainly: (1) simple, easy, and can be prepared at low
cost; (2) screening for a large number of strains is a simple repetitive process;
(3) the large number of metabolites formed allows easier detection, isolation, and
structural identification; (4) newer metabolites can be isolated; (5) utilized for
synthetic reactions involving many steps; (6) useful in cases where regio- and
stereospecificity is required; (7) maintenance of stock cultures of microorganisms
is simpler and cheaper than the maintenance of cell or tissue cultures or laboratory
animals; (8) ease of setup and manipulation; and (9) more reliable and
reproducible [8, 9].
The objective of this review is to highlight the importance of microorganisms or
enzymes isolated from them in the biotransformation process of natural products
or xenobiotic compounds, according to green chemistry or white biotechnology.
2. Microbiological transformations of some selected natural products
with different microorganisms
2.1 Sesquiterpene lactone
Artemisinin (1), a sesquiterpene lactone endoperoxide and an antimalarial drug,
is effective against chloroquine-resistant parasites; but its toxicities and low solu-
bility in water hamper its therapeutical use. Studies on modification of 1 through
biological and chemical methodologies have been reported to yield more effective
and water-soluble derivatives. A wide array of microbial transformations of 1
involve oxidation, reduction, and degradation reactions by different microorgan-
isms, such as Aspergillus niger, A. flavus, A. adametzi (ATCC 10407),
Cunninghamella echinulata, Caenorhabditis elegans, Mucor polymorphous, M.
rammanianus, Streptomyces griseus, Penicillium simplicissimum, P. chrysogenum, P.
purpuresceus, Pestalotiopsis guepini (P-8), Eurotium amstelodami,Trichoderma viride
(T-58), Saccharomyces cerevisiae, and Pichia pastoris. Biotransformation of 1 usually
includes the processes such as hydroxylation of methyl, methine and methylene
groups, deoxidation reactions, hydration and acetylation reactions, epimerization,
and breakdown of heterocyclic rings (Table 1).
2.2 Triterpene
Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid, UA, 2), a natural pentacyclic
triterpene, is broadly used in food, cosmetics, and biomedical industries. As a
ubiquitous constituent in the plant kingdom and the major component of many
traditional medicine herbs, ursolic acid remarkably exhibits a lot of biological
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activities, such as antibacterial, anti-allergic, antioxidative, anti-inflammation, and
antitumor activities [18].
Microbial transformation of ursolic acid (2) by Bacillus megaterium CGMCC
1.1741 yielded five metabolites identified as 3-oxo-urs-12-en-28-oic acid (3, 6.2%);
1β,11α-dihydroxy-3-oxo-urs-12-en-28-oic acid (4, 13.5%); 1β-hydroxy-3-oxo-urs-12-
en-28,13-lactone (5, 5.0%); 1β,3β,11α-trihydroxy-urs-12-en-28-oic acid (6, 26.9%);
and 1β,11α-dihydroxy-3-oxo-urs-12-en-28-O-β-D-glucopyranoside (7, 8.6%) [19].
The biotransformation studies of 2 by Alternaria longipes AS 3.2875 have led to the
isolation of six products of hydroxylation or glycosylation. Their structures were
identified as 3-carbonyl-ursolic acid-28-O-β-D-glucopyranosyl ester (8), ursolic acid-
3-O-β-D-glucopyranoside (9), ursolic acid-28-O-β-D-glucopyranosyl ester (10),
2α,3β-dihydroxy-ursolic acid-28-O-β-D-glucopyranosyl ester (11), 3β,21β-dihydroxy-
ursolic acid-28-O-β-D-glucopyranosyl ester (12), and 3-O-(β-D-glucopyranosyl)-
ursolic acid-28-O-(β-D-glucopyranosyl) ester (13). Glycosylation reaction on
pentacyclic triterpenoid fulfilled with difficulty in the process of chemical synthesis is
facile by microbial transformation [20]. Biotransformation of 2 by A. alternata eight
metabolites were found to be 2α,3β-dihydroxyurs-12-en-28-oic acid (corosolic acid,
14), urs-12-en-2α,3β,28-triol (15), 3β,23-dihydroxyurs-12-en-28-oic acid (16),
2α,3β,23-trihydroxyurs-12-en-28-oic acid (17), 2α,3β,23,24-tetrahydroxyurs-12-en-
28-oic acid (18), 3β,28-dihydroxy-12-ursene (19), urs-12-en-3β-ol (20), and urs-12-
en-2α,3β-diol (21). The reduction of the C-28 carboxyl group and hydroxylation at C-
2, 23, and 24 are steps in the metabolic pathway of 2 [21].
Microorganism Products Action Reference
A. niger 3β-hydroxy-4,12-epoxy-1-
deoxyartemisinin
Artemisinin G
3,13-epoxyartemisinin
4α-hydroxy-1-
deoxyartemisinin
Epoxidation, hydroxylation C-3β site
Endoperoxide function reduction
Breakdown of heterocyclic rings
Epoxidation C-3 and C-13
Hydroxylation C-4, endoperoxide
function reduction
[10]
A. flavus (MTCC
9167)
14-hydroxyartemisinin
Artemisinin G
4α-hydroxydeoxyartemisinin
Deoxyartemisinin
Hydroxylation of C-14 site
Breakdown of heterocyclic rings
Hydroxylation of C-4α site
Endoperoxide function reduction
[11, 12]
C. elegans
(ATCC 9245)
7β-hydroxy-9α-artemisinin
4α-hydroxy-1-
deoxoartemisinin
7β-hydroxyartemisinin
6β-hydroxyartemisinin
7α-hydroxyartemisinin
6β,7α-dihydroxyartemisinin
Hydroxylation C-7β site
Epimerization C-9
Hydroxylation C-4α site
Hydroxylation C-7β site
Hydroxylation C-6β site
Hydroxylation C-7α site
Hydroxylation C-6β and C-7α sites
[13, 14]
P.
simplicissimum
9β-acetoxyartimisinin
9α-hydroxyartemisinin
Acetylation of C-9β site
Hydroxylation of C-9α site
[15]
R. stolonifer Deoxyartemisinin
1α-hydroxyartemisinin
10β-hydroxyartemisinin
Endoperoxide function reduction
Hydroxylation of C-1 site
[16]
S. griseus (ATCC
13273)
9-artemisitone
9α-hydroxyartemisinin
9β-hydroxyartemisinin
3α-hydroxyartemisinin
Oxidation of C-9 site
Hydroxylation of C-9α site
Hydroxylation of C-9β site
Hydroxylation of C-3α site
[17]
N. corallina Deoxyartemisinin Endoperoxide function reduction [11]
Table 1.
Products obtained from the biotransformation of artemisinin (1) by different microorganisms.
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Biotransformation of UA by S. racemosum (3.2500) yielded five metabolites
3β,7β,21β-trihydroxy-urs-12-en-28-oic acid (22); 3β,21β-dihydroxy-urs-11-en-28-oic
acid-13-lactone (23); 1β,3β,21β-trihydroxy-urs-12-en-28-oic acid (24);
3β,7β,21β-trihydroxy-urs-1-en-28-oic acid-13-lactone (25); and 1β,3β-dihydroxy-
urs-12-en-21-oxo-28-oic acid (26) which were afforded [22]. Additionally, of the
biotransformation of 2 with by S. racemosum compounds 27–30 and 11,26-epoxy-
3β-21β-dihydroxy-urs-12-en-28-oic acid were obtained (31), (Figure 1) [23].
The endophytic fungi Pestalotiopsis microspora isolated from medical plant
Huperzia serrata can transform 1 to afforded 3-oxo-15β,30-dihydroxy-urs-12-en-28-
oic acid (32), 3β,15β-dihydroxy-urs-12-en-28-oic acid (33), 3β,15β,30-trihydroxy-
urs-12-en-28-oic acid (34), and 30 [24].
Microbial transformation of ursolic acid byMucor spinosus AS 3.3450 were
isolated and their structures were identified as 9, 22 and 3β,7β-dihydroxy-ursolic
acid-28-ethanone (35) (Figure 1) [25].
The gum resin Boswellia serrata has been used for the treatment of inflammatory
and arthritic diseases. Its major active constituents are ursane triterpenoids, which
include 11-keto-β-boswellic acid (KBA, 36), β-boswellic acid (BA), and acetyl-β-
boswellic acid (ABA). Microbial transformation 36 by Cunninghamella blakesleeana
(AS 3.970) yielded ten regioselective transformed products: 7β-hydroxy-11-keto-β-
boswellic acid (37), 7β,15α-dihydroxy-11-keto-β-boswellic acid (38), 7β,16β-
dihydroxy-11-keto-β-boswellic acid (39), 7β,16α-dihydroxy-11-keto-β-boswellic
acid (40), 7β,22β-dihydroxy-11-keto-β-boswellic acid (41), 7β,21β-dihydroxy-11-
keto-β-boswellic acid (42), 7β,20β-dihydroxy-11-keto-β-boswellic acid (43), 7β,30-
dihydroxy-11-keto-β-boswellic acid (44), 3α,7β-dihydroxy-11-oxours-12-en,24,30-
dioic acid (45), and 3α,7β-dihydroxy-30-(2-hydroxypropanoyloxy)-11-oxours-12-
en, 24-oic acid (46). Bioconversion of 36 with Bacillus megaterium based on a
recombinant cytochrome P450 system yielded regio- and stereoselective 15α-
hydroxylation (47) of substrate (Figure 2) [26].
Figure 1.
Biotransformation products of ursolic acid (2).
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18β-glycyrrhetinic acid (48) is the active form of glycyrrhizin which is the major
pentacyclic triterpene found in licorice (Glycyrrhiza glabra L.). Glycyrrhetinic acid
has been shown to possess several pharmacological activities, such as antiulcerative,
anti-inflammatory, immunomodulating, antitumor, antiviral, antihepatitis effects,
and anticancer. Biotransformation 48 with a fungus C. blakesleeana (AS 3.970)
yielded 3-oxo-7β-hydroxyglycyrrhetinic acid (49) and 7β-hydroxyglycyrrhetinic
acid (50) [27], while of 48 using Absidia pseudocylindrospora (ATCC 24169),
Gliocladium viride (ATCC 10097) and Cunninghamella echinulata (ATCC 8688a)
afforded seven derivatives: 51, 52, 7β,15α-dihydroxy-18β-glycyrrhetinic acid (53),
15α-hydroxy-18β-glycyrrhetinic acid (54), 1α-hydroxy-18β-glycyrrhetinic acid (55)
and 13β-hydroxy-7α,27-oxy-12-dihydro-18β-glycyrrhetinic acid (56), and the epi-
mer of compound 53 on C-17 (Figure 3) [28].
Ginsenoside Rb1 (61) is the most predominant protopanaxadiol-type
ginsenoside in Panax species (ginseng). Several microbial transformations of this
substrate (Ginsenoside Rb1) have been accomplished with an ample and varied
group of microorganisms, all of these having β-glucosidase activities.
Figure 3.
Biotransformation products of 18β-glycyrrhetinic acid (48).
Figure 2.
Biotransformation products of 11-keto-b-boswellic acid (36).
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Deglycosylation appears to be the major transformation pathway, and the interme-
diate and the final hydrolysis products of 61 depended on the microorganisms used.
The biotransformation of various triterpenes, such as 61–64, has been described in
the literature. For each triterpenoid, the transforming microorganism together with
the type and site of the reaction catalyzed is given in Table 2 (Figure 4) [29].
Biotransformation of oleanolic acid (62) with Bacillus subtilis (ATCC 6633)
resulted in five more polar metabolites as 28-O-β-D-glucopyranosyl oleanic acid
(63), 3β-O-β-D-glucopyranosyl oleanic acid (64), 3-O-(β-D-glucopyranosyl)-oleanic
acid-28-O-β-D-glucopyranoside (61), 24-hydroxyl-oleanolic acid (62), and 3β-
24-dihydroxy-olean-12-en-28-O-β-D-glucopyranosyl-oic acid (63), while
echinocystic acid (64, 250 mg) was metabolized to three more polar metabolites as
28-O-β-D-glucopyranosyl echinocystic acid (65), 3-O-(β-D-glucopyranosyl)-
echinocystic acid-28-O-β-D-glucopyranoside (66), and 24-hydroxyl-28-O-β-
glucopyranosyl echinocytic acid (67), and then biotransformation of betulinic acid
(68) contributed four metabolites as 28-O-β-D-glucopyranosyl betulinic acid (69),
3-O-(β-D-glucopyranosyl)-betulinic acid-28-O-β-D-glucopyranoside (70),
23-hydroxy-betulinic acid (71), and 23-hydroxy-28-O-D-β-glucopyranosyl betulinic
acid (72). In this way there were two types of reactions in the biotransformation of
triterpenic acids 58, 64, and 68: hydroxylation and glycosylation [41]. Biotransfor-
mation of 58 by C. muscae yielded nine hydroxylated and glycosylated metabolites.
The specific hydroxylation (7β, 15α, and 21β) was main reaction type. In addition,
the selective glycosylation at C-28 was another main reaction type. It was also
observed that the 3β-OH group was selectively dehydrogenated into carbonyl
group [42].
A C-3 oxidized derivative of oleanolic acid 73 (3-oxoolean-12-en-28-oic acid)
was transformed by the Chaetomium longirostre (RF-1095) into 4-hydroxy-3,4-seco-
olean-12-ene-3,28-dioic acid (74) and the corresponding 21-hydroxylated deriva-
tive (75). Analogous ring-A cleavage oxidation reactions have been observed in the
biotransformation of triterpenoid substrates with the fungi Septomyxa affinis ATCC
6737 and Glomerella fusarioides ATCC 9552. (Figure 5) [4, 43].
2.3 Steroidal saponins
Diosgenin [(25R)-spirost-5-en-3β-ol, 76] is an important natural starting mate-
rial in the pharmaceutical industry to produce steroid drugs and hormones since the
last century. In recent years, a wide array of new biological activities of 76 has been
disclosed. Diosgenin was subjected to several structural modification studies to
secure new derivatives via microbial transformation. Several microorganisms have
been found to be capable of degrading 76, Bacillus megaterium, Corynebacterium
mediolanum,Mycobacterium fortuitum,M. phlei, Nocardia rhodochrous, and F. solani.
Figure 4.
Triterpenic acid: ginsenoside Rb1 (61), oleanolic acid (62), betulinic (63) and betulonic acid (64).
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Three major products were accumulated, diosgenone (77), 1-dehydrodiosgenone
(78), androst-4-en-3,17-dione (AD, 79), and androsta-1,4-diene-3,17-dione
(ADD, 80) (Table 3) [44, 45]. In addition, two side-chain cleavage intermediates of
76 were produced by C. elegans and Aspergillus nidulans. Microbial transformation
Triterpenoid Microorganism Reaction Reference
Ginsenoside
Rb1 (61)
A. niger (KTC
6909)
Deglycosylation at the C-3 and C-20 sites [30]
A. niger (AS
3.1858)
Deglycosylation at the C-3 and C-20 sites [30]
A. usamii (KTC
6956)
Deglycosylation at the C-3 and C-20 sites [30]
F. sacchari Deglycosylation at the C-3 and C-20 sites [31]
P. oxalicum Deglycosylation at the C-3 site [32]
C. lunata (AS
3.1109)
Deglycosylation at the C-20 site, hydration Δ24(25)
Formation of tertiary alcohol
[33]
R. stolonifer (AS
3.822)
Deglycosylation at the C-3 and C-20 sites [33]
Oleanolic
acid (62)
C. blakesleeana Diverse hydroxylation at the C-1β, C-7β, C-13β sites [4]
F. lini Dehydrogenation C-13 and C-18. oleanderolide
formation
[4]
P. chrysogenum Hydroxylation on C-21. Oxidation of the hydroxyl
group in C-3
[4]
C. phomoides Hydroxylation in C-6β [4]
A. ochraceus (NG
1203)
Hydroxylation in C-11α [4]
Chaetomium
longirostre
Oxidative ring A cleavage, hydroxylation at the C-21β
sites
[34]
Nocardia sp.
(NRRL 5646)
Methyl esterification of the C-28 carboxyl group [4]
R. miehei (CECT
2749)
Hydroxylation of the C-7β, C-15α and C-30 sites
Deshidrogenation Δ9(11)
[35]
Betulinic
acid (63)
B. megaterium
(ATCC 14581)
Dehydrogenation of the C-3 secondary alcohol group,
hydroxylation at the C-6α and C-7β sites
[36]
B. megaterium
(ATCC 13368)
Dehydrogenation of the C-3 secondary alcohol group,
hydroxylation at the C-7β and C-15α sites
[37]
C. elegans
(ATCC 9244)
Hydroxylation at the C-1β and C-7β sites [4]
Cunninghamella
sp.
Introduction of a β-glucopyranosyl at the C-28
carboxylic acid group
[38]
Betulonic
acid (64)
B. megaterium
(ATCC 13368)
Ketone α-hydroxylation at the C-2 site [37]
Ch. longirostris Oxidative ring A cleavage, hydroxylation,
decarboxylation
[39]
C. lunata (ATCC
13432)
Hydroxylations at the C-7β and (or) C-15β sites [4, 40]
Table 2.
Examples of biotransformed triterpenes (61–64) with different microorganisms.
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of 76 using white-rot fungus Coriolus versicolor afforded eight polyhydroxylated
steroids, 7β-hydroxydiosgenin (81), (25R)-spirost-5-en-3β,7β,21-triol (82), (25R)-
spirost-5-en-3β,7β,12β-triol (83), (25R)-spirost-5-en-3β,7α,15α,21-tetraol (84),
(25R)-spirost-5-en-3β,7β,12β,21-tetraol (85), (25R)-spirost-5-en-3β,7α,12β,21-
tetraol (86), and (25R)-spirost-5-en-3β,7β,11α,21-tetraol (87). The 3β-hydroxyl
group and double bond in the B-ring of 76 were found to be important structural
determinants for their activity [46].
Microbial transformation of 76 using Cunninghamella blakesleeana AS 3.970
afforded polyhydroxylated derivatives, such as (25R)-spirost-5-en-3β,7α,12β-triol
(88), (25R)-spirost-5-en-3β,7α,12β,15α,21-pentaol (89), (25R)-spirost-5-en-
3β,7α,12β,18-tetraol (90), (25R)-spirost-5-en-3β,7α,12β,15α-tetraol (91), (25R)-
spirost-5-en-3β,7α,11α,21-tetraol (92), (25R)-spirost-5-en-3β,7β,15α,21-tetraol (93),
and (25R)-spirost-5-en-3β,7β,12β,18-tetraol (94) [47], specifically, the hydroxyl-
ation, ketonization, and methoxylation by Cunninghamella blakesleeana, C. elegans,
Helicostylum piriforme, and Streptomyces virginiae, at C-7, C-9, C-11, C-12, and C-25
positions of 76. Biotransformation of 76 by Syncephalastrum racemosum afforded
(25R)-spirost-5-en-3β,7α,9α-triol (95, 1%), (25R)-spirost-5-en-3β,9α,12α-triol-7-
one (96, 2%), (25R)-spirost-5-en-3β,9α-diol-7,12-dione (97, 1.5%), (25R)-spirost-4-
en-9α,12β,14α-triol-3-one (98, 0.66%), and (25S)-spirost-4-en-9α,14α,25β-triol-3-
one (99, 0.66%) [48]. C. echinulata (CGMCC3.2716) metabolized 76 to afford 81
(0.9%), 83 (7.7%), (25R)-spirost-5-en-3β,7β-diol-11-one (100, 7, 1.5%), and (25R)-
spirost-5-en-3β,7β,11α-triol (101, 6.2%) (Figure 6) [49].
2.4 Steroids
Microorganisms are able to hydroxylate steroids in different positions C-1 to
C-21. These represent the most widespread type of steroid bioconversion carried
Figure 5.
Biotransformation products of oleanolic acid (62), echnocystic acid (68) and betulinic acid (63).
Fungi Diosgenona (77) AD (79) ADD (80) Progesterone (102) 16-AD
A. nidulans ++ ++ ++ ++
C elegans ++ ++
F. solani ++ ++
Rhizopus sp. ++ ++ ++
AD androst-4-ene-3,17-dione; ADD androsta1,4-diene-3,17-dione; 16-AD androst-4-ene-3,16-dione.
Table 3.
The ability of different fungi to transform diosgenin (76).
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out by fungi. The commercialized microbial process in the steroid field was in the
production of 11α-hydroxyprogesterone. This process was realized for the first time
by Peterson and Murray (1952), which patented this process of 11α-hydroxylation
of progesterone (102) by Rhizopus species [50]. Microbial hydroxylation of 102 by
A. griseola produced two hydroxylated pregnane identified as 6β,14α-dihydroxy-
progesterone (103) and 7α,14α-dihydroxyprogesterone (104). R. pusillus produced
6β,11α-dihydroxyprogesterone (105) with excellent yield (65.5%) and 7α,14α-
dihydroxyprogesterone (106) (Figure 7) [51].
Industry, which is carried by different microorganisms, such as different
species of Curvularia spp., Cunninghamella spp. and fungi Trichoderma hamatum,
Cochliobolus lunatus. Structural transformation of steroidal compounds through
microorganisms has emerged as an important application in the steroidal drug
industry. Microbial conversions of steroids generally involve dehydrogenation,
esterification, halogenation, isomerization, methoxylation, and side-chain modifi-
cation of steroidal skeleton. Recently, Mucor circinelloides lusitanicus transformed
5-en-3β-ol steroids (108 and 109) into di- and trihydroxy products. The compound
Figure 6.
Biotransformation products of diosgenin (76).
Figure 7.
Biotransformation products of progesterone (102).
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108 yielded 3β,7α,11α-trihydroxypregna-5-en-20-one (110, 46.4%), and 109
afforded 111 (3β,7α-dihydroxyandrost-5-en-17-one, 43.6%) (Figure 8) [52].
Microbial transformation of (20S)-20-hydroxymethylpregna-1,4-dien-3-one
(112) is by four filamentous fungi, Cunninghamella elegans (113–119),
Macrophomina phaseolina (115, 117, 120–122), Rhizopus stolonifer (113, 123), and
Gibberella fujikuroi (115–117, 123). These metabolites were obtained as a
result of biohydroxylation of 112 at C-6β, 7β, 11α, 14α, 15β, 16β, and 17α positions
(Figure 9) [53].
The 11α-, 11β-, 15α, and 16α-hydroxylations are currently established processes
in the steroid industry mainly for the production of adrenal cortex hormones and
their analogues. 11α-, 11β-, and 16α-hydroxylations are usually performed using
Rhizopus spp. or Aspergillus spp., Curvularia spp. or Cunninghamella spp. and Strep-
tomyces spp., respectively (Figure 10) (Table 4) [54].
Boldenone (124) is an important steroid hormone drug which is the derivative
of testosterone. Biotransformation of 124 by Arthrobacter simplex and recombinant
Pichia pastoris with 17β-hydroxysteroid dehydrogenase from Saccharomyces
cerevisiae produces BD (124) from androst-4-ene-3,17-dione (79, AD) efficiently [65].
Many microorganisms such asMucor racemosus, Nostoc muscorum, and Arthrobacter
oxydans can utilize androst-1,4-diene-3,17-dione (80, ADD) as substrate to produce
testosterone through 17β-carbonyl reduction reactions (Table 5). The ability of
Figure 8.
Biotransformation products of 5-en-3β-ol steroids.
Figure 9.
Biotransformation products of (20S)-20-hydroxymethylpregna-1, 4-dien-3-one (112).
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microorganisms to reduce 17-keto- to 17β-hydroxysteroids was evidenced for a wide
variety of substrates and microorganisms of different taxonomy: bacteria, fungi,
and yeast [54, 56, 57, 66].
Figure 10.
The ability of different microorganism to transform progesterone (102).
Hydroxylation
sites
Microorganisms Applications Reference
C-7α Fusarium sp., Gibberella sp.,
Nigrospora sp., Acremonium
sp., Phycomyces sp.
Production of bile acids and drugs for
neuropsychiatry and immunology
[55, 56]
C-7β Mortierella sp. Obtaining drugs for prostate cancer [56, 57]
11β Curvularia sp., Absidia sp.,
Cunninghamella sp.,
Trichoderma sp., Cochliobolus
sp.
Obtaining anti-inflammatory drugs,
like hydrocortisone, prednisone acetate,
dexamethasone
[56–60]
11α Aspergillus sp., Rhizopus sp. Obtaining of anti-inflammatory,
immunosuppressive, anti-allergic
drugs, and production of contraceptive
drugs
[56, 61]
14α Mucor sp. [56]
15β Bacillus sp. [56, 62]
16α Streptomyces sp. [63, 64]
Table 4.
Some examples of steroid hydroxylation reactions promoted by microorganisms and their applications.
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The oxidation of 17β-hydroxyl group was observed along with hydroxylation of
steroids at C5 (Penicillium crustosum, P. chrysogenum), C6 (Bacillus stearother-
mophilus, B. obtusa, P. blakesleeanus), C7 (α/β) (A. coerulea, Botrytis cinerea, B. obtusa,
P. blakesleeanus, Rhizopus stolonifer), C10 (Absidia glauca), C11 (α/β) (A. coerulea, B.
obtusa, Cephalosporium aphidicola, R. stolonifer), C12 (A. glauca, B. obtusa), C14 (Bacil-
lus sp.), and C15 (A. glauca, Aspergillus fumigatus, B. obtusa) [54, 56, 57, 67–69]. The
biotransformation of 79 with different microorganisms is shown. Compound 79 is an
endogenous weak androgen steroid hormone and intermediate in the biosynthesis of
estrone and of testosterone from dehydroepiandrosterone (DHEA) [70]. DHEA is an
endogenous steroid hormone. It functions as a metabolic intermediate in the biosyn-
thesis of the androgen and estrogen sex steroids. Various microorganisms have had
the ability to biotransform steroidal compounds such as AD (79) [54], DHEA (125)
Fungi Yeast Bacteria
Actinomucor elegans
Agaricus silvaticus
A. pantherina
A. spissa
Armillaria mellea
Corticium centrifugum
Fusarium spp.
Gibberella saubinetti
Mucor spp.
Penicillium spp.
Aphanocladium album
Aspergillus chevalieri
A. flavus
A. oryzae
A. tamarii
B. obtusa
C. aphidicola
Ceratocystis paradoxa
C. lunatus
Colletotrichum musae
C. radicicola
Exophiala jeanselmei var.
lecaniicorni
Fusarium
culmorum
F. oxysporum var.
cubense
F. solani
Mucor piriformis
M. spinosus
P. chrysogenum
P. crustosum
P. blakesleeanus
R. stolonifer
Septomyxa affinis
T. piriforme
Trichoderma
viride
Zygodesmus sp.
Candida albicans
C. pelliculosa
C. pseudotropicalis
C. robusta
C. tropicalis
C. utilis
Cryptococcus
albidus
C. laurentii
C. tsukubaensis
Debaryomyces
hansenii
D. kloeckeri
D. nicotianae
D. subglobosus
D. vini
Hansenula
anomala
H. califórnica
H. schnegii
H. suaveolens
Kloeckera jensenii
Saccharomyces
carlsbergensis
S. cerevisiae
S. fragilis
S. lactis
S. oviformis
S. turbidans
S. validus
Pichia farinosa
P.
membranaefaciens
Torulopsis spp.
Hortaea werneckii
Phaeotheca
triangularis
P. herbarum
P. ostreatus
Rhodotorula
aurantiaca
R. mucilaginosa
B. stearothermophilus
Bacteroides fragilis
Brevibacterium sterolicum
Clostridium paraputrificum
Comamonas testosteroni
Lactobacillus bulgaricus
Mycobacterium spp.
B. stearothermophilus
Bacteroides fragilis
Brevibacterium sterolicum
Clostridium paraputrificum
Comamonas testosteroni (syn.
Pseudomonas testosteroni)
Lactobacillus bulgaricus
Pediococcus cerevisiae
Sarcina lutea
Staphylococcus aureus
Streptomyces globisporus
S. sphaeroides
S. viridochromogenes
S. hydrogenans
S. lavendulae
Table 5.
Reduction of the C-17 carbonyl group of steroids by (17βHSDs) different microorganisms.
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[54, 55, 70–73, 76, 77, 80, 81], testosterone [54, 55, 74–76, 81], cortexolone (126)
[78, 79], and prednisone (127) (Figure 11a–d) [54, 55, 82].
2.5 Diterpene
Sclareolide (128) is a natural product isolated from several plant species which
displays phytotoxic and cytotoxic activities against several human tumor cells lines.
This compound has also been used as starting material for the synthesis of various
bioactive products. Regarding the biotransformation of the 128 with different
microorganisms, mono- (130, 131, 135, 140–142) and dihydroxylation (132–134,
136, 139, 143, 146), oxidation (129, 144), hydroxylation/oxidation (145),
epimerization (137), and cyclization (138) products have been obtained [83]. The
microbial transformation of 128 by Curvularia lunata yielded 3-ketoesclareolide
(129), 1β-hydroxysclareolide (130), 3β-hydroxysclareolide (131), 1α,3β-dihydroxy-
sclareolide (133), and 1β,3β-dihydroxysclareolide (134) [84]. The incubation of 128
with Cunninghamella elegans afforded 129, 131, 133, and 135–137 [85]. C
blakesleeana metabolized 128 to afford 129, 135, 134, and 138–140. Biotransforma-
tion of 128 with C. echinulata yielded 5-hydroxysclareolide (141) and 7β-
hydroxysclareolide (142) [86]. Fermentation of 148 with A. niger using a nutrient-
rich culture medium yielded 141 and 144–146 (Figure 12) [83].
2.6 Flavonoids
As most important phytochemicals in food, the dietary flavonoids exert a wide
range of benefits for human health. Recent researches have explored diverse bio-
logical and pharmacological activities of natural flavonoids—antioxidant activity,
anti-inflammatory activity, anti-Alzheimer’s disease, antibacterial activity, antifun-
gal activity, anti-HIV activity, anticoagulant activity, antileishmanial activity, and
Figure 11.
The ability of different fungi to transform DHEA (125), testosterone, cortexolone (126) and prednisone (127).
(a) Hydroxilation of 3β-hydroxy-5-androsten-17-one (DHEA) by various microorganisms. (b) Reduction of
C-17 and hydroxilation of testosterone by various microorganisms. (c) Hydroxylation of cortexolone (123) by
various microorganisms. (d) Reduction and hydroxylation of prednisone (126) microorganisms.
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anti-obesity activity [87–91]. Microbial biotransformation strategies for production
of flavonoids have attracted considerable interest because they allow yielding novel
flavonoids, which do not exist in nature.
The main reactions during microbial biotransformation are hydroxylation,
dehydroxylation, O-methylation, O-demethylation, glycosylation, deglycosylation,
dehydrogenation, hydrogenation, C ring cleavage of the benzo-γ-pyrone system,
cyclization, and carbonyl reduction. Cunninghamella, Penicillium, and Aspergillus
strains are very popular to biotransform flavonoids, and they can perform almost all
the reactions with excellent yields (Figure 13). Isoflavones are usually hydroxylated
at the C-30 position of the B ring by microorganisms. Chalcones 147-152 were
regioselectively cyclized to flavanones (Figure 14). Hydrogenation of flavonoids
was only reported on transformation of chalcones to dihydrochalcones (Figure 14)
[92, 93].
Aspergillus niger is one of the most applied microorganisms in the flavonoids’
biotransformation; for example, A. niger can transfer flavanone to flavan-4-ol, 20-
hydroxydihydrochalcone, flavone, 3-hydroxyflavone, 6-hydroxyflavanone, and 40-
hydroxyflavanone. The hydroxylation of flavones by microbes usually happens on
the ortho position of the hydroxyl group on the A ring and C-40 position of the B
ring, and microbes commonly hydroxylate flavonols at the C-8 position. Natural
flavonoids, such as naringenin (166), hesperetin (167), chrysin (168), apigenin
(169), and luteolin (170) were subjected to microbiological transformations by
Rhodotorula glutinis (KCh 735). Yeast was able to regioselectively C-8 hydroxylate
167, 168, 169, and 170 to generate 171 (17%), 172 (31%), 173 (12.9%), and 174
(25%), respectively. Naringenin (166) was transformed to carthamidin (175) and
isocarthamidin (176) in a ratio of 1:19, respectively (Figure 15) [94].
Figure 12.
Biotransformation products of sclareolide (128).
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The microorganisms tend to hydroxylate flavanones at the C-5, 6, and 40 posi-
tions; however, for prenylated flavanones, dihydroxylation often takes place on the
Δ4(5) double bond on the prenyl group (the side chain of A ring), although cycliza-
tion of the prenyl group to dihydrofurane derivatives is rather common biotrans-
formation pathway of prenylated flavonoids. Prenylated flavanones are a unique
class of naturally occurring flavonoids characterized by the presence of a prenylated
side chain (prenyl, geranyl) in the flavonoid skeleton [95]. The prenyl chain gener-
ally refers to the 3,3-dimethylallyl substituent (3,3-DMA), geranyl and lavandulyl.
It is proposed that the prenyl-moiety makes the backbone compound more lipo-
philic, which leads to its high affinity with cell membranes. The prenylation brings
the flavonoids with enhancement of antibacterial, anti-inflammatory, antioxidant,
cytotoxicity, larvicidal, as well as estrogenic activities. Figure 16 demonstrated
Figure 14.
Biotransformation products obtained from biotransformation of chalcones 147-152 with A. niger.
Figure 13.
The main reactions during biotransformation of chalcone whit microorganisms.
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the microbial biotransformation of kurarinone (177) using C. echinulata and C.
militaris [96, 97].
Incubation of Absidia coerulea (AM93) with prenylnaringenin (178) led to
metabolite 179 (8-prenylnaringenin 7-O-β-D-glucopyranoside, 49.3%), while B.
bassiana transformed 178 into 180 (8-prenylnaringenin 7-O-β-D-4″-O-methyl-
glucopyranoside, 32.9%); the metabolites 179 and 180 originated in Sabouraud
medium. In the absence of glucose in the culture of A. coerulea, the sulfation of
substrate 178 (8-prenylnaringenin-7-sulfate, 181, 31.1%) occurs, while B. bassiana
into the same product (180). The capacity of some fungi—Cunninghamella elegans,
Streptomyces fulvissimus,Mucor ramannianus, and B. bassiana—in the sulfation of
certain phenolic compounds has been reported (Figure 17) [98].
Regioselective glycosylation of biologically active flavonoid aglycones catalyzed
by microorganisms is an interesting and desired reaction, which significantly
increases the water solubility of the compound and, therefore, may improve bio-
availability of flavonoids. Absidia glauca AM177, A. coerulea AM93, Rhizopus nigricans
UPF701, Beauveria bassiana AM278, and B. bassiana AM446 are able to conjugate
Figure 16.
Microbial biotransformation of kurarinone (177) using C. echinulate and C. militaris.
Figure 15.
Biotransformation products of flavanone (166, 167) and flavone (168–170).
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sugar moiety to chalcones, flavanones, and isoflavanones with high regioselectivity.
Therefore, it is possible to use Beauveria and Absidia for the microbial transformation
of simple or prenylated flavonoids by glycosidation reactions [97, 99].
Bavachinin (182) is one kind compound of flavanones and isolated from the
aerial parts and dried fruits of Psoralea corylifolia, and bavachinin displays a broad
range of biological activities, such as antioxidant, antibacterial, antifungal, anti-
inflammatory, antitumor, anti-pyretic, and analgesic properties [100, 101].
Bavachinin (182) was subject to biotransformation by cultured cells of A. flavus
(ATCC 30899); C. elegans (CICC 40250) afforded the same product 183 [(S)-6-
((R)-2,3-dihydroxy-3-methylbutyl)-2-(4-hydroxyphenyl)-7-methoxychromen-4-
one]. On the other hand, one major product 184 [(2S,4R)-2-(4-hydroxyphenyl)-7-
methoxy-6-(3-methylbut-2-en-1-yl)-chromen-4-ol] was obtained by P. raistrickii
(ATCC 10490) by the reduction at the position of ketone group of the C-ring
(Figure 18) [102].
The biotransformation of xanthohumol (185), a prenylated chalcone isolated
from hops by selected fungi, Absidia coerulea (AM93), Rhizopus nigricans (UPF701),
Mortierella mutabilis (AM404), and Beauveria bassiana (AM446), was investigated.
The incubation of A. coerulea with 185 resulted in the isolation of xanthohumol 40-
O-β-D-glucopyranoside (186, 29%). This metabolite was also produced by R.
nigricans (186, 14.2%). Biotransformation of 185 with B. bassiana andM. mutabilis
yielded xanthohumol 7-O-β-D(4‴-O-methyl)-glucopyranoside (187, 23%) and
isoxanthohumol 7-O-β-glucopyranoside (188, 49%), respectively (Figure 19) [103].
The compounds 188 (9.3%) and 186 (12%) were also observed as products of 185
transformation by Cunninghamella elegans [104]. Another way to obtain 188 is by
the transformation of isoxanthohumol (189, 61.6%) with Absidia glauca; although
Figure 17.
Biotransformation products of prenylnaringenin (178).
Figure 18.
Biotransformation products of bavachinina (182).
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the efficiency of this process was high (61.6% yield), it required the chemical
isomerization of 185 to 189, prior to biotransformation [105].
2″-(2″-hydroxyisopropyl)-dihydrofurano-[4″,5″:30,40]-4,20-dihydroxy-60-
methoxychalcone (190), mixture of diastereoisomers of (2S, 2″S) and (2S, 2″R) 2″-
(2″-hydroxyisopropyl)-dihydrofurano-[4″,5″:7,8]-40-hydroxy-5-methoxyflavanone
(191), and (Z)-2″-(2″-hydroxyisopropyl)-dihydrofurano-[4″,5″-6,7]-30,40-
dihydroxy-4-methoxyaurone (192) were obtained by transformation of 185 in
Aspergillus ochraceus (AM 465) culture (Figure 19) [106].
Incubation of xanthohumol (185) both with Fusarium avenaceum (AM11) and F.
oxysporum (AM727) gave a single metabolite 2″-(2″-hydroxyisopropyl)-dihy-
drofurano-[4″,5″:30,40]-40,2-dihydroxy-60-methoxy-α,β-dihydrochalcone (193),
which turned out to be the product of the prenyl group cyclization and α,β-double
bond reduction. F. tricinctum reduced α,β-double bond of 185 to give 4,20,40-trihy-
droxy-60-methoxy-3-prenyl-α,β-dihydrochalcone (194). Penicillium albidum
(AM79) oxidized 185 at the double bond of prenyl group to xanthohumol H (195)
[107]. The culture of the yeast, Rhodotorula marina (AM 77), converted 185 and 4-
methoxychalcone (196) to α,β-dihydroxanthohumol (197) and 4-methoxydihydro-
chalcone (198) with the yields of 18% and 20%, respectively [108]. Penicillium
albidum (AM79) dihydroxylated the Δ2″(3″) double bond of xanthohumol to pro-
duce 30-[3″-hydroxy-3″-methylbutyl]-4,20,40-trihydroxy-60-methoxychalcone (199,
22.84%) (Figure 19).
B. bassiana AM278 and Absidia glauca AM177 converted isoxanthohumol (189)
into glucoside derivatives (200, 201), whereas Fusarium equiseti AM15 transformed
it into (2R)-2-(2-hydroxyisopropyl)-dihydrofurano-[2,3:7,8]-4-hydroxy5-
methoxyflavanone (202) (Figure 20) [95, 106].
C. echinulata (ATCC 9244) sulfated silybin (203) to silybin-7-sulfate (204) and
2,3-dehydrosylibin-7-sulfate (205). Sulfonation at the C-7 position of silybin
Figure 19.
Biotransformation products of xanthohumol (185).
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significantly decreased the DPPH free radical scavenging potential; however, fur-
ther dehydrogenation Δ2(3) to 2,3-dehydrosilbyn-7-sulfate (206) drastically
enhanced the DPPH free radical scavenging potential activity [109] (Figure 21).
2.7 Enzymes isolated from microorganisms and their application
Enzymes are the most proficient catalysts, offering much more competitive
processes than chemical catalysts. A number of enzyme-based processes have been
commercialized for producing several valuable products. During the 1980s and
1990s, engineering of enzymes based on structural information allowed extension
of their substrate ranges, enabling the synthesis of unusual intermediates. Accord-
ingly, the use of enzymes has been expanded to the manufacture of pharmaceutical
intermediates and fine chemicals [110]. Microorganisms and enzymes
(biocatalysts) are highly enantio-, chemo-, and regioselective in a wide range of
reaction conditions. Selectivity is extremely desirable in the synthesis of different
synthesis products, since it offers advantages such as minimizing the side reactions
that do not require protection and deprotection steps, which allows for shorter
synthesis. Biocatalysis provides a technology that is environmentally safer, and it
effectively reduces the level of waste and even eliminates the waste generation
rather than remediation and disposal of wastes at the end of the process. In addition
Figure 20.
Biotransformation products of isoxanthohumol (189).
Figure 21.
Biotransformation products of sylbin (204).
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to, biocatalysts have many attractive features in the context of green chemistry and
sustainable development. Various enzymes used in different industrial processes
have been described in the literature. Table 6 indicates some enzymes, their source,
and some applications [111–113].
2.8 Extremophiles
A very interesting research area in biology and biotechnology is the of extremo-
phile microorganisms. Extremophiles can be divided into group according to (i)
temperature tolerance, (ii) salt concentration, (iii) pH range, or (iv) pressure condi-
tions. Enzymes from extremophilic microorganisms offer versatile tools for
Microbial enzymes Microorganism Application
α-Amylase Bacillus
amyloliquefaciens
B. stearothermophilus
B. licheniformis
Baking, brewing, starch liquefaction
Clarification of fruit juice
Textile industry
Paper industry
Glucoamylase Aspergillus niger
A. awamori
Rhizopus oryzae
Beer production
High glucose and high fructose syrups
Proteases A. usami
Lactase (β-
galactosidase)
Kluyveromyces lactis
K. fragilis
Lactose intolerance reduction in people
Prebiotic food ingredients
Lipase Candida antarctica
C. cylindraceae Ay30
Helvina lanuginosa
Pseudomonas sp.
Geotrichum candidum
Cheese flavor development
Textile indutry
Medicinal applications
Use in cosmetics
Use as biosensors
Use in biodegradation
Phospholipases Fusarium oxysporum Cheese flavor development
Esterases Bacillus licheniformis Enhancement of flavor and fragrance in fruit juice
Xylanases Streptomyces sp.
Bacillus sp.
Pseudomonas sp.
Clarification of fruit juice
Beer quality improvement
Glucose oxidase A. niger
Penicillium glaucum
P. adametzzi
Food shelf life important
Food flavor improvement
Laccase Funalia trogii
Bacillus licheniformis
Bacillus vallismortis
Polyphenol removal from wine
baking
Pectinases A. niger
A. wentii
Rhizopus sp.
Clarification of fruit juice
Catalase A. niger
Metarhizium
anisopliae
Psychrobacter
piscatorri
Food preservation
Removal of H2O2 from milk prior to cheese
production
Peroxidase Streptomyces
viridosporus
Development of flavor, color and nutritional quality
of food
Table 6.
Enzymes, source, and some applications.
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sustainable developments in a variety of industrial applications as they show impor-
tant environmental benefits due to their biodegradability, specific stability under
extreme conditions, improved use of raw materials, and decreased amount of waste
products. Although major advances have been made in the last decade, our knowl-
edge of the physiology, metabolism, enzymology, and genetics of this fascinating
group of extremophilic microorganisms and their related enzymes is still limited
[114–116].
The outstanding properties of thermozymes are suited to industries that employ
elevated temperatures, such as the pulp and paper, food, brewing, and feed
processing industries. Thermophiles are often highly resistant to harsh conditions
such as chemical denaturing agents, wide pH ranges, and/or nonaqueous solvents.
Examples of such enzymes are cellulases, xylanases, pectinases, chitinases, amy-
lases, pullulanases, proteases, lipases, glucose isomerases, alcohol dehydrogenases,
and esterases. Thermophilic enzymes have played important roles not only at the
industrial level but also in pharmaceutical applications requiring use of specific
aldolases for the synthesis of enantiopure compounds (Table 7) [118].
Source Enzyme Activity Bioprocess/industry Reference
Sulfolobus
solfataricus
S. acidocaldarius
Thermoproteus
texas
Hyperthermus
butylicus
Aldolase Stereoselective C-C bond
formation
Pharmaceutical
industry
[117]
Pyrococcus
furiosus
Hydrogenase Final stage of glucose
oxidation by oxidative
pentose phosphate cycle
Enhanced production
of biohydrogen
[119]
Geobacillus
thermoleovorans
Carboxylesterase Carboxyl ester hydrolysis Agriculture, food, and
pharmaceutical
industries
[120]
Bacillus pumilus Acidic
thermostable
lipase
Degradation of palm oil Treatment of palm oil-
containing wastewater
[121]
Geobacillus sp. Lipase Hydrolysis of diver’s lipid
substrates
Biofuel, cosmetics, or
perfume production,
leather and pulp
industries
[122]
Microbial
community
from solid-state
fermentation
reactor
Protease Degradation of hair waste
from tannery
Leather industry [123]
Sulfolobus
tokodaii
Chitinase Hydrolysis of β-(1, 4)-
glycosidic bonds in chitin
Biomedical,
pharmaceutical, food,
and environmental
[124]
Acidothermus
cellulolyticus
Endoxylanase β-(1,4)-xylan cleavage Biofuel production
from lignocellulose
[125]
Thermotoga
neapolitana
Pullulanase Hydrolysis of α-(1, 6)-
glucosidic linkages
Biofuel production [126]
Table 7.
Extremophile microorganisms and some applications of their enzymes.
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3. Conclusion
Due to microorganisms’ abundant multienzyme systems, microbial transforma-
tion possesses advantages against chemosynthesis of environmental friendliness,
mild reaction conditions, and high stereo-, regio, and chemo-selectivities as well as in
improving conversion rates and reducing cost. Thus, microbial transformation
technique is being increasingly used to structurally modify natural and synthetic
compounds.
The hydrolytic and reductive capabilities of microorganisms have been known
and are currently used in preparative and industrial reactions. Various classes of
bioactive organic compounds have been subjected to enzymatic transformation to
obtain more active and less toxic substances or to elucidate their metabolic path-
ways.
For example, biotransformation-derived steroids are used for a wide range of
pharmacotherapeutic purposes, such as anti-inflammatory, immunosuppressive,
progestational, diuretic, anabolic, as neurosteroids, and as contraceptive.
Researchers continue to discover more useful steroid compounds and to isolate
microorganisms that can perform the structural transformations desired. New
technologies such as genomics, metanogenomics, gene shuffling, and DNA evolu-
tion provide valuable tools for improving or adapting enzyme properties to the
desired requirements.
An alternative may be extremophilic microorganisms such as biocatalysts for
countless future industrial applications that are more environmentally friendly.
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